AI-generated summary
This review examines microneedle technology combined with various therapies for hair regrowth in alopecia, including drug delivery, biologics, stem cells, and low-level laser therapy. The authors report on advances over the past five years and note a disconnect between basic research and clinical trials. The abstract does not report pooled outcomes or a clear measure of effectiveness.
- Who or what was studied
- people with alopecia (hair loss)
- Limits stated in the abstract
- The abstract is a narrative review that reports no pooled outcomes, and it notes a gap between basic research and clinical trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.